25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BCWORLD PHARM. Co. Ltd
Buy, Hold or Sell?

Let's analyze BCWORLD PHARM. Co. Ltd together

I guess you are interested in BCWORLD PHARM. Co. Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of BCWORLD PHARM. Co. Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about BCWORLD PHARM. Co. Ltd

I send you an email if I find something interesting about BCWORLD PHARM. Co. Ltd.

1. Quick Overview

1.1. Quick analysis of BCWORLD PHARM. Co. Ltd (30 sec.)










1.2. What can you expect buying and holding a share of BCWORLD PHARM. Co. Ltd? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
74.1%

What is your share worth?

Current worth
₩9,000.53
Expected worth in 1 year
₩7,922.38
How sure are you?
66.7%

+ What do you gain per year?

Total Gains per Share
₩-1,078.16
Return On Investment
-23.9%

For what price can you sell your share?

Current Price per Share
₩4,510.00
Expected price per share
₩0 - ₩4,770
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of BCWORLD PHARM. Co. Ltd (5 min.)




Live pricePrice per Share (EOD)
₩4,510.00

2.2. Growth of BCWORLD PHARM. Co. Ltd (5 min.)




Is BCWORLD PHARM. Co. Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$53.1m$57m-$1.6m-2.9%

How much money is BCWORLD PHARM. Co. Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$1.2m$959.2k-$2.1m-179.5%
Net Profit Margin-9.2%7.4%--

How much money comes from the company's main activities?

2.3. Financial Health of BCWORLD PHARM. Co. Ltd (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of BCWORLD PHARM. Co. Ltd?

Welcome investor! BCWORLD PHARM. Co. Ltd's management wants to use your money to grow the business. In return you get a share of BCWORLD PHARM. Co. Ltd.

First you should know what it really means to hold a share of BCWORLD PHARM. Co. Ltd. And how you can make/lose money.

Speculation

The Price per Share of BCWORLD PHARM. Co. Ltd is ₩4,510. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of BCWORLD PHARM. Co. Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in BCWORLD PHARM. Co. Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩9,000.53. Based on the TTM, the Book Value Change Per Share is ₩-269.54 per quarter. Based on the YOY, the Book Value Change Per Share is ₩128.73 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of BCWORLD PHARM. Co. Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.160.0%-0.140.0%0.110.0%0.010.0%0.050.0%
Usd Book Value Change Per Share-0.150.0%-0.190.0%0.090.0%-0.080.0%0.230.0%
Usd Dividend Per Share0.000.0%0.000.0%0.050.0%0.040.0%0.040.0%
Usd Total Gains Per Share-0.150.0%-0.190.0%0.140.0%-0.040.0%0.270.0%
Usd Price Per Share3.92-4.45-5.06-9.17-11.13-
Price to Earnings Ratio-6.09-35.20--19.36-38.91-35.32-
Price-to-Total Gains Ratio-26.95--24.57--60.01-62.84-72.77-
Price to Book Ratio0.62-0.68-0.75-1.38-1.54-
Price-to-Total Gains Ratio-26.95--24.57--60.01-62.84-72.77-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.157
Number of shares316
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.04
Usd Book Value Change Per Share-0.19-0.08
Usd Total Gains Per Share-0.19-0.04
Gains per Quarter (316 shares)-59.62-12.38
Gains per Year (316 shares)-238.49-49.51
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-238-24848-98-60
20-477-48696-195-110
30-715-724144-293-160
40-954-962192-390-210
50-1192-1200240-488-260
60-1431-1438288-585-310
70-1669-1676336-683-360
80-1908-1914384-780-410
90-2146-2152432-878-460
100-2385-2390480-975-510

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%6.06.00.050.0%12.08.00.060.0%19.08.00.070.4%19.08.00.070.4%
Book Value Change Per Share0.04.00.00.0%4.08.00.033.3%10.010.00.050.0%16.010.01.059.3%16.010.01.059.3%
Dividend per Share0.00.04.00.0%6.00.06.050.0%13.00.07.065.0%20.00.07.074.1%20.00.07.074.1%
Total Gains per Share0.04.00.00.0%4.08.00.033.3%11.09.00.055.0%18.09.00.066.7%18.09.00.066.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of BCWORLD PHARM. Co. Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---207.825-269.539+30%128.729-261%-110.245-47%333.353-162%
Book Value Per Share--9000.5359378.479-4%9623.754-6%9704.003-7%9525.829-6%
Current Ratio--0.5160.507+2%0.537-4%0.758-32%0.929-44%
Debt To Asset Ratio--0.5730.567+1%0.560+2%0.513+12%0.467+23%
Debt To Equity Ratio--1.3121.278+3%1.274+3%1.069+23%0.938+40%
Dividend Per Share----0%66.396-100%54.285-100%55.942-100%
Eps---229.983-204.326-11%162.433-242%17.063-1448%75.625-404%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap38057905600.000-24%47255964000.00053669273400.000-12%61129093250.000-23%131016757148.894-64%149555798744.364-68%
Net Profit Margin---0.100-0.092-8%0.074-235%0.018-668%0.054-286%
Operating Margin----0%0.010-100%0.024-100%0.060-100%
Operating Ratio--1.3701.522-10%1.160+18%0.996+37%1.089+26%
Pb Ratio0.501-24%0.6220.678-8%0.752-17%1.383-55%1.538-60%
Pe Ratio-4.903+19%-6.08735.196-117%-19.356+218%38.907-116%35.318-117%
Price Per Share4510.000-24%5600.0006360.000-12%7225.000-22%13107.000-57%15905.185-65%
Price To Free Cash Flow Ratio----1.2660%1.435-100%-7.2460%-10.5650%
Price To Total Gains Ratio-21.701+19%-26.946-24.568-9%-60.009+123%62.836-143%72.769-137%
Quick Ratio---0.170-100%0.351-100%0.374-100%0.466-100%
Return On Assets---0.011-0.010-13%0.007-247%0.001-941%0.004-366%
Return On Equity---0.025-0.022-14%0.016-256%0.002-1346%0.008-426%
Total Gains Per Share---207.825-269.539+30%195.125-207%-55.960-73%389.295-153%
Usd Book Value--53166117.90055398634.251-4%57003738.768-7%63511618.429-16%60923101.209-13%
Usd Book Value Change Per Share---0.145-0.189+30%0.090-261%-0.077-47%0.233-162%
Usd Book Value Per Share--6.3006.565-4%6.737-6%6.793-7%6.668-6%
Usd Dividend Per Share----0%0.046-100%0.038-100%0.039-100%
Usd Eps---0.161-0.143-11%0.114-242%0.012-1448%0.053-404%
Usd Free Cash Flow---819627.228-100%1015209.447-100%-2717648.4530%-2834178.5220%
Usd Market Cap26640533.920-24%33079174.80037568491.380-12%42790365.275-23%91711730.004-64%104689059.121-68%
Usd Price Per Share3.157-24%3.9204.452-12%5.058-22%9.175-57%11.134-65%
Usd Profit---1358509.600-1206952.348-11%959212.804-242%158783.487-956%491255.088-377%
Usd Revenue--13622112.70012767870.217+7%13337299.133+2%11535902.566+18%10927868.001+25%
Usd Total Gains Per Share---0.145-0.189+30%0.137-207%-0.039-73%0.273-153%
 EOD+3 -4MRQTTM+10 -17YOY+5 -265Y+4 -2510Y+4 -25

3.3 Fundamental Score

Let's check the fundamental score of BCWORLD PHARM. Co. Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.903
Price to Book Ratio (EOD)Between0-10.501
Net Profit Margin (MRQ)Greater than0-0.100
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.516
Debt to Asset Ratio (MRQ)Less than10.573
Debt to Equity Ratio (MRQ)Less than11.312
Return on Equity (MRQ)Greater than0.15-0.025
Return on Assets (MRQ)Greater than0.05-0.011
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of BCWORLD PHARM. Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose4,600.000
Total1/1 (100.0%)

4. In-depth Analysis

4.1 About BCWORLD PHARM. Co. Ltd

BCWORLD PHARM. Co., Ltd. operates as a pharmaceutical company in South Korea. The company provides products in various therapeutic areas comprising musculoskeletal system, digestive system, circulatory machine, central nervous system, adrenocorticosteroids, narcotic analgesics, erectile dysfunction treatment, wellbeing injection, diuretic, antitussive expectorant, vaginitis treatment, anti-tuberculosis drugs, anti-emetic, antiviral drugs, antibiotic, anti-malignant tumor drugs, antifungal agent, antihistamines, antidote, and antipyretic/analgesic/anti-inflammatory. BCWORLD PHARM. Co., Ltd. was founded in 1980 and is headquartered in Seongnam-si, South Korea.

Fundamental data was last updated by Penke on 2024-11-19 10:53:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit BCWORLD PHARM. Co. Ltd earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare BCWORLD PHARM. Co. Ltd to the Drug Manufacturers - General industry mean.
  • A Net Profit Margin of -10.0% means that ₩-0.10 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BCWORLD PHARM. Co. Ltd:

  • The MRQ is -10.0%. The company is making a loss. -1
  • The TTM is -9.2%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-10.0%TTM-9.2%-0.8%
TTM-9.2%YOY7.4%-16.6%
TTM-9.2%5Y1.8%-11.0%
5Y1.8%10Y5.4%-3.6%
4.3.1.2. Return on Assets

Shows how efficient BCWORLD PHARM. Co. Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare BCWORLD PHARM. Co. Ltd to the Drug Manufacturers - General industry mean.
  • -1.1% Return on Assets means that BCWORLD PHARM. Co. Ltd generated ₩-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BCWORLD PHARM. Co. Ltd:

  • The MRQ is -1.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.1%TTM-1.0%-0.1%
TTM-1.0%YOY0.7%-1.7%
TTM-1.0%5Y0.1%-1.1%
5Y0.1%10Y0.4%-0.3%
4.3.1.3. Return on Equity

Shows how efficient BCWORLD PHARM. Co. Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare BCWORLD PHARM. Co. Ltd to the Drug Manufacturers - General industry mean.
  • -2.5% Return on Equity means BCWORLD PHARM. Co. Ltd generated ₩-0.03 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BCWORLD PHARM. Co. Ltd:

  • The MRQ is -2.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -2.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.5%TTM-2.2%-0.3%
TTM-2.2%YOY1.6%-3.8%
TTM-2.2%5Y0.2%-2.4%
5Y0.2%10Y0.8%-0.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of BCWORLD PHARM. Co. Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient BCWORLD PHARM. Co. Ltd is operating .

  • Measures how much profit BCWORLD PHARM. Co. Ltd makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare BCWORLD PHARM. Co. Ltd to the Drug Manufacturers - General industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BCWORLD PHARM. Co. Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY1.0%-1.0%
TTM-5Y2.4%-2.4%
5Y2.4%10Y6.0%-3.6%
4.3.2.2. Operating Ratio

Measures how efficient BCWORLD PHARM. Co. Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • An Operation Ratio of 1.37 means that the operating costs are ₩1.37 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of BCWORLD PHARM. Co. Ltd:

  • The MRQ is 1.370. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.522. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.370TTM1.522-0.153
TTM1.522YOY1.160+0.362
TTM1.5225Y0.996+0.526
5Y0.99610Y1.089-0.093
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of BCWORLD PHARM. Co. Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if BCWORLD PHARM. Co. Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A Current Ratio of 0.52 means the company has ₩0.52 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of BCWORLD PHARM. Co. Ltd:

  • The MRQ is 0.516. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.507. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.516TTM0.507+0.008
TTM0.507YOY0.537-0.030
TTM0.5075Y0.758-0.250
5Y0.75810Y0.929-0.172
4.4.3.2. Quick Ratio

Measures if BCWORLD PHARM. Co. Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare BCWORLD PHARM. Co. Ltd to the Drug Manufacturers - General industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BCWORLD PHARM. Co. Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.170-0.170
TTM0.170YOY0.351-0.180
TTM0.1705Y0.374-0.204
5Y0.37410Y0.466-0.092
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of BCWORLD PHARM. Co. Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of BCWORLD PHARM. Co. Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare BCWORLD PHARM. Co. Ltd to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.57 means that BCWORLD PHARM. Co. Ltd assets are financed with 57.3% credit (debt) and the remaining percentage (100% - 57.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of BCWORLD PHARM. Co. Ltd:

  • The MRQ is 0.573. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.567. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.573TTM0.567+0.006
TTM0.567YOY0.560+0.007
TTM0.5675Y0.513+0.054
5Y0.51310Y0.467+0.046
4.5.4.2. Debt to Equity Ratio

Measures if BCWORLD PHARM. Co. Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare BCWORLD PHARM. Co. Ltd to the Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 131.2% means that company has ₩1.31 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BCWORLD PHARM. Co. Ltd:

  • The MRQ is 1.312. The company is able to pay all its debts with equity. +1
  • The TTM is 1.278. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.312TTM1.278+0.033
TTM1.278YOY1.274+0.004
TTM1.2785Y1.069+0.209
5Y1.06910Y0.938+0.131
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings BCWORLD PHARM. Co. Ltd generates.

  • Above 15 is considered overpriced but always compare BCWORLD PHARM. Co. Ltd to the Drug Manufacturers - General industry mean.
  • A PE ratio of -6.09 means the investor is paying ₩-6.09 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BCWORLD PHARM. Co. Ltd:

  • The EOD is -4.903. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.087. Based on the earnings, the company is expensive. -2
  • The TTM is 35.196. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD-4.903MRQ-6.087+1.185
MRQ-6.087TTM35.196-41.283
TTM35.196YOY-19.356+54.552
TTM35.1965Y38.907-3.711
5Y38.90710Y35.318+3.589
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of BCWORLD PHARM. Co. Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-1.266+1.266
TTM-1.266YOY1.435-2.701
TTM-1.2665Y-7.246+5.980
5Y-7.24610Y-10.565+3.319
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of BCWORLD PHARM. Co. Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 0.62 means the investor is paying ₩0.62 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of BCWORLD PHARM. Co. Ltd:

  • The EOD is 0.501. Based on the equity, the company is cheap. +2
  • The MRQ is 0.622. Based on the equity, the company is cheap. +2
  • The TTM is 0.678. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.501MRQ0.622-0.121
MRQ0.622TTM0.678-0.056
TTM0.678YOY0.752-0.074
TTM0.6785Y1.383-0.706
5Y1.38310Y1.538-0.155
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets177,751,848
Total Liabilities101,800,251
Total Stockholder Equity77,610,126
 As reported
Total Liabilities 101,800,251
Total Stockholder Equity+ 77,610,126
Total Assets = 177,751,848

Assets

Total Assets177,751,848
Total Current Assets44,178,924
Long-term Assets133,572,924
Total Current Assets
Total Current Assets  (as reported)44,178,924
Total Current Assets  (calculated)0
+/- 44,178,924
Long-term Assets
Long-term Assets  (as reported)133,572,924
Long-term Assets  (calculated)0
+/- 133,572,924

Liabilities & Shareholders' Equity

Total Current Liabilities85,671,054
Long-term Liabilities16,129,197
Total Stockholder Equity77,610,126
Total Current Liabilities
Total Current Liabilities  (as reported)85,671,054
Total Current Liabilities  (calculated)0
+/- 85,671,054
Long-term Liabilities
Long-term Liabilities  (as reported)16,129,197
Long-term Liabilities  (calculated)0
+/- 16,129,197
Total Stockholder Equity
Total Stockholder Equity (as reported)77,610,126
Total Stockholder Equity (calculated)0
+/- 77,610,126
Other
Common Stock Shares Outstanding 8,439
Net Invested Capital 77,610,126
Net Working Capital -41,492,130



6.2. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-03-31
> Total Assets 
0
119,891,272
138,880,477
139,404,610
161,739,030
163,803,773
164,429,776
168,699,130
172,776,345
174,331,562
187,187,694
189,870,772
192,963,967
190,869,519
198,431,640
200,953,959
179,358,374
208,098,486
189,287,026
191,395,198
183,050,719
181,311,656
184,684,038
188,208,913
184,110,789
180,331,223
177,751,848
177,751,848180,331,223184,110,789188,208,913184,684,038181,311,656183,050,719191,395,198189,287,026208,098,486179,358,374200,953,959198,431,640190,869,519192,963,967189,870,772187,187,694174,331,562172,776,345168,699,130164,429,776163,803,773161,739,030139,404,610138,880,477119,891,2720
   > Total Current Assets 
0
39,655,971
49,847,890
46,327,624
46,305,672
43,276,891
40,292,929
41,542,012
43,310,714
43,566,865
53,805,975
54,969,790
53,693,221
46,583,076
49,675,786
49,058,597
37,234,633
52,549,641
41,252,296
45,587,386
43,609,397
43,213,291
43,272,179
47,215,700
48,085,729
45,175,930
44,178,924
44,178,92445,175,93048,085,72947,215,70043,272,17943,213,29143,609,39745,587,38641,252,29652,549,64137,234,63349,058,59749,675,78646,583,07653,693,22154,969,79053,805,97543,566,86543,310,71441,542,01240,292,92943,276,89146,305,67246,327,62449,847,89039,655,9710
       Cash And Cash Equivalents 
0
1,087,912
6,287,031
2,287,362
2,392,706
2,652,484
845,449
2,049,971
1,685,097
2,907,135
10,953,743
9,137,825
10,679,522
3,797,139
764
1,859
2,166
3,461
1,275
1,318
1,105
1,049
1,501
5,965,309
6,995,599
4,135,572
0
04,135,5726,995,5995,965,3091,5011,0491,1051,3181,2753,4612,1661,8597643,797,13910,679,5229,137,82510,953,7432,907,1351,685,0972,049,971845,4492,652,4842,392,7062,287,3626,287,0311,087,9120
       Short-term Investments 
0
1,020,000
1,740,000
2,740,000
2,380,000
2,020,000
1,260,000
1,980,000
1,770,000
0
0
2,130,000
1,880,000
2,109,101
2,014,348
2,400,203
1,746,385
1,429,322
2,248,733
3,940,798
4,025,491
3,936,495
3,141,513
4,170,000
4,170,000
4,170,000
0
04,170,0004,170,0004,170,0003,141,5133,936,4954,025,4913,940,7982,248,7331,429,3221,746,3852,400,2032,014,3482,109,1011,880,0002,130,000001,770,0001,980,0001,260,0002,020,0002,380,0002,740,0001,740,0001,020,0000
       Net Receivables 
0
21,457,362
22,145,028
22,807,224
21,055,384
18,533,076
18,233,770
16,572,662
16,136,904
15,880,824
15,577,403
15,222,054
14,712,393
13,534,942
14,488,444
13,924,098
15,049,963
15,621,047
17,866,521
16,848,116
17,778,287
17,862,364
17,299,301
17,699,478
18,190,435
14,866,786
0
014,866,78618,190,43517,699,47817,299,30117,862,36417,778,28716,848,11617,866,52115,621,04715,049,96313,924,09814,488,44413,534,94214,712,39315,222,05415,577,40315,880,82416,136,90416,572,66218,233,77018,533,07621,055,38422,807,22422,145,02821,457,3620
       Other Current Assets 
0
570,179
158,358
111,899
129,652
162,326
71,133
169,709
55,605
334,725
114,915
42,053
161,647
349,926
0
0
0
0
239,605
209,036
579,459
0
0
0
1
-2
0
0-21000579,459209,036239,6050000349,926161,64742,053114,915334,72555,605169,70971,133162,326129,652111,899158,358570,1790
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
139,441,322
111,645,275
141,411,860
140,993,213
136,025,059
135,155,292
133,572,924
133,572,924135,155,292136,025,059140,993,213141,411,860111,645,275139,441,32200000000000000000000
       Property Plant Equipment 
0
75,477,724
82,170,259
86,985,371
109,727,312
114,365,771
118,193,452
121,199,634
122,880,855
125,171,238
127,744,889
126,730,665
130,908,416
134,029,260
137,958,349
141,759,825
132,369,839
146,231,269
138,692,746
137,312,883
130,118,686
105,066,811
128,113,352
127,109,620
125,628,107
124,722,444
0
0124,722,444125,628,107127,109,620128,113,352105,066,811130,118,686137,312,883138,692,746146,231,269132,369,839141,759,825137,958,349134,029,260130,908,416126,730,665127,744,889125,171,238122,880,855121,199,634118,193,452114,365,771109,727,31286,985,37182,170,25975,477,7240
       Long Term Investments 
0
431,586
3,232,256
2,633,764
1,698,668
2,081,668
2,134,168
1,857,574
1,994,154
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000001,994,1541,857,5742,134,1682,081,6681,698,6682,633,7643,232,256431,5860
       Intangible Assets 
0
1,407,737
1,431,313
1,720,432
1,699,231
1,679,423
1,555,907
1,437,567
1,295,510
1,307,103
1,079,864
1,203,608
1,174,792
2,261,754
2,258,174
2,265,647
2,265,766
2,237,992
2,829,642
2,841,812
2,827,552
2,771,697
2,994,676
3,036,674
2,997,045
2,918,261
0
02,918,2612,997,0453,036,6742,994,6762,771,6972,827,5522,841,8122,829,6422,237,9922,265,7662,265,6472,258,1742,261,7541,174,7921,203,6081,079,8641,307,1031,295,5101,437,5671,555,9071,679,4231,699,2311,720,4321,431,3131,407,7370
       Other Assets 
0
4,757,577
2,198,759
1,737,419
2,308,147
2,400,020
2,253,319
2,662,341
3,295,112
3,924,202
4,152,811
4,146,797
3,884,966
3,919,247
4,212,310
2,785,934
3,731,721
3,417,402
3,487,538
4,429,243
5,132,974
4,769,455
8,421,681
0
0
0
0
00008,421,6814,769,4555,132,9744,429,2433,487,5383,417,4023,731,7212,785,9344,212,3103,919,2473,884,9664,146,7974,152,8113,924,2023,295,1122,662,3412,253,3192,400,0202,308,1471,737,4192,198,7594,757,5770
> Total Liabilities 
0
37,257,005
52,060,766
50,847,622
71,443,991
72,178,931
69,087,245
73,898,920
75,534,936
75,649,109
86,265,176
88,034,202
91,269,792
88,844,762
94,778,960
96,476,236
97,900,583
104,231,327
107,626,078
109,495,375
103,498,786
102,077,490
99,634,309
105,171,690
104,241,328
102,625,879
101,800,251
101,800,251102,625,879104,241,328105,171,69099,634,309102,077,490103,498,786109,495,375107,626,078104,231,32797,900,58396,476,23694,778,96088,844,76291,269,79288,034,20286,265,17675,649,10975,534,93673,898,92069,087,24572,178,93171,443,99150,847,62252,060,76637,257,0050
   > Total Current Liabilities 
0
20,297,946
26,257,437
25,260,548
32,794,182
28,806,122
30,219,806
37,282,753
40,760,138
43,755,069
45,884,610
52,022,074
55,518,429
55,324,612
58,393,684
56,061,645
55,892,475
65,617,166
72,505,651
75,411,825
84,206,064
78,706,442
90,524,821
94,892,283
92,246,451
91,248,140
85,671,054
85,671,05491,248,14092,246,45194,892,28390,524,82178,706,44284,206,06475,411,82572,505,65165,617,16655,892,47556,061,64558,393,68455,324,61255,518,42952,022,07445,884,61043,755,06940,760,13837,282,75330,219,80628,806,12232,794,18225,260,54826,257,43720,297,9460
       Short-term Debt 
12,177,689
2,517,344
3,007,979
3,322,320
3,753,260
4,027,760
6,316,880
13,390,000
13,240,000
16,915,000
24,550,000
24,550,000
26,550,000
26,733,793
29,550,000
29,550,000
30,100,000
30,350,000
33,620,000
36,520,000
35,550,000
36,605,000
37,550,000
0
0
0
0
000037,550,00036,605,00035,550,00036,520,00033,620,00030,350,00030,100,00029,550,00029,550,00026,733,79326,550,00024,550,00024,550,00016,915,00013,240,00013,390,0006,316,8804,027,7603,753,2603,322,3203,007,9792,517,34412,177,689
       Short Long Term Debt 
12,177,689
2,517,344
3,007,979
3,322,320
3,753,260
4,027,760
6,316,880
10,154,424
9,773,833
0
0
0
0
0
0
0
0
0
0
0
72,867,268
33,710,417
80,120,349
82,318,427
79,648,841
78,656,626
0
078,656,62679,648,84182,318,42780,120,34933,710,41772,867,268000000000009,773,83310,154,4246,316,8804,027,7603,753,2603,322,3203,007,9792,517,34412,177,689
       Accounts payable 
0
5,429,385
7,223,032
5,890,438
4,512,482
4,374,498
4,206,151
3,016,489
6,117,564
3,962,207
4,364,058
4,008,284
4,106,242
3,061,702
0
0
0
0
3,945,330
4,681,279
4,066,623
3,762,945
3,710,267
4,175,421
4,232,074
4,524,202
0
04,524,2024,232,0744,175,4213,710,2673,762,9454,066,6234,681,2793,945,33000003,061,7024,106,2424,008,2844,364,0583,962,2076,117,5643,016,4894,206,1514,374,4984,512,4825,890,4387,223,0325,429,3850
       Other Current Liabilities 
0
5,801,217
8,706,018
8,987,173
17,074,755
13,304,178
12,284,163
10,319,519
11,214,119
12,229,236
6,329,937
11,432,332
7,562,613
8,103,962
0
0
0
0
9,663,870
7,303,413
6,805,478
-1
1
0
-1
-1
0
0-1-101-16,805,4787,303,4139,663,87000008,103,9627,562,61311,432,3326,329,93712,229,23611,214,11910,319,51912,284,16313,304,17817,074,7558,987,1738,706,0185,801,2170
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21,324,771
25,288,855
11,192,014
10,279,407
11,994,877
11,377,738
16,129,197
16,129,19711,377,73811,994,87710,279,40711,192,01425,288,85521,324,77100000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
36,728,622
34,753,931
32,418,734
41,200,837
36,988,014
32,697,777
31,179,347
34,210,392
38,484,377
43,818,640
37,097,192
34,147,704
33,816,004
21,324,771
25,509,636
11,192,014
0
0
0
0
000011,192,01425,509,63621,324,77133,816,00434,147,70437,097,19243,818,64038,484,37734,210,39231,179,34732,697,77736,988,01441,200,83732,418,73434,753,93136,728,6220000000
       Other Liabilities 
0
1,589,054
1,610,029
4,548,628
-1
0
-1
0
-2
0
0
-1
4,500,000
4,200,000
0
0
0
0
2,700,000
2,400,000
0
0
0
0
0
0
0
00000002,400,0002,700,00000004,200,0004,500,000-100-20-10-14,548,6281,610,0291,589,0540
> Total Stockholder Equity
73,875,913
82,413,506
86,660,549
88,066,899
90,087,972
91,523,001
93,388,051
94,800,210
97,241,409
98,682,454
100,922,518
101,836,570
101,694,176
102,024,757
103,652,680
104,477,723
81,457,791
103,867,160
81,660,948
81,899,822
79,551,933
79,234,166
85,049,729
85,137,029
81,642,993
79,550,855
77,610,126
77,610,12679,550,85581,642,99385,137,02985,049,72979,234,16679,551,93381,899,82281,660,948103,867,16081,457,791104,477,723103,652,680102,024,757101,694,176101,836,570100,922,51898,682,45497,241,40994,800,21093,388,05191,523,00190,087,97288,066,89986,660,54982,413,50673,875,913
   Common Stock
0
1,461,871
1,601,664
1,601,664
1,601,664
1,601,664
1,601,664
1,601,664
1,601,664
1,754,784
1,778,477
1,778,477
1,778,477
1,778,477
1,778,477
1,778,477
1,778,477
1,778,477
1,778,477
1,778,477
1,778,477
1,778,477
1,778,477
0
0
0
0
00001,778,4771,778,4771,778,4771,778,4771,778,4771,778,4771,778,4771,778,4771,778,4771,778,4771,778,4771,778,4771,778,4771,754,7841,601,6641,601,6641,601,6641,601,6641,601,6641,601,6641,601,6641,461,8710
   Retained Earnings Total Equity000000000000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
31,845,605
31,845,605
31,845,605
34,068,269
34,068,269
34,068,269
34,068,269
34,068,269
34,068,269
34,068,269
34,068,269
34,068,269
34,068,269
34,068,269
34,068,269
34,068,269
0
0
0
0
000034,068,26934,068,26934,068,26934,068,26934,068,26934,068,26934,068,26934,068,26934,068,26934,068,26934,068,26934,068,26934,068,26931,845,60531,845,60531,845,6050000000
   Treasury Stock0000000000-771,621-771,621-771,621-771,621-771,621-771,621-771,621-747,305-747,305-747,305000-271,635-271,635-241,2810
   Other Stockholders Equity 
0
72,190
2,105,999
1,628,639
852,930
1,140,749
1,165,320
878,995
3,201,077
2,246,357
0
-161,861
100,654
57,231
878,995
878,995
878,995
878,995
-30,288
0
0
878,995
-699,195
0
0
0
0
0000-699,195878,99500-30,288878,995878,995878,995878,99557,231100,654-161,86102,246,3573,201,077878,9951,165,3201,140,749852,9301,628,6392,105,99972,1900



6.3. Balance Sheets

Currency in KRW. All numbers in thousands.




6.4. Cash Flows

Currency in KRW. All numbers in thousands.




6.5. Income Statements

Currency in KRW. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue75,110,699
Cost of Revenue-43,147,558
Gross Profit31,963,14131,963,141
 
Operating Income (+$)
Gross Profit31,963,141
Operating Expense-68,745,540
Operating Income6,365,159-36,782,399
 
Operating Expense (+$)
Research Development1,198,478
Selling General Administrative8,584,471
Selling And Marketing Expenses0
Operating Expense68,745,5409,782,949
 
Net Interest Income (+$)
Interest Income179,848
Interest Expense-5,234,000
Other Finance Cost-0
Net Interest Income-5,054,152
 
Pretax Income (+$)
Operating Income6,365,159
Net Interest Income-5,054,152
Other Non-Operating Income Expenses0
Income Before Tax (EBT)1,206,1336,365,159
EBIT - interestExpense = -5,234,000
2,633,791
7,867,791
Interest Expense5,234,000
Earnings Before Interest and Taxes (EBIT)06,440,133
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax1,206,133
Tax Provision--1,686,176
Net Income From Continuing Ops2,892,3092,892,309
Net Income2,633,791
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net05,054,152
 

Technical Analysis of BCWORLD PHARM. Co. Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of BCWORLD PHARM. Co. Ltd. The general trend of BCWORLD PHARM. Co. Ltd is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine BCWORLD PHARM. Co. Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of BCWORLD PHARM. Co. Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 4,750 < 4,760 < 4,770.

The bearish price targets are: .

Tweet this
BCWORLD PHARM. Co. Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of BCWORLD PHARM. Co. Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

BCWORLD PHARM. Co. Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of BCWORLD PHARM. Co. Ltd.

BCWORLD PHARM. Co. Ltd Daily Moving Average Convergence/Divergence (MACD) ChartBCWORLD PHARM. Co. Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of BCWORLD PHARM. Co. Ltd. The current adx is .

BCWORLD PHARM. Co. Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of BCWORLD PHARM. Co. Ltd.

BCWORLD PHARM. Co. Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of BCWORLD PHARM. Co. Ltd.

BCWORLD PHARM. Co. Ltd Daily Relative Strength Index (RSI) ChartBCWORLD PHARM. Co. Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of BCWORLD PHARM. Co. Ltd.

BCWORLD PHARM. Co. Ltd Daily Stochastic Oscillator ChartBCWORLD PHARM. Co. Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of BCWORLD PHARM. Co. Ltd.

BCWORLD PHARM. Co. Ltd Daily Commodity Channel Index (CCI) ChartBCWORLD PHARM. Co. Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of BCWORLD PHARM. Co. Ltd.

BCWORLD PHARM. Co. Ltd Daily Chande Momentum Oscillator (CMO) ChartBCWORLD PHARM. Co. Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of BCWORLD PHARM. Co. Ltd.

BCWORLD PHARM. Co. Ltd Daily Williams %R ChartBCWORLD PHARM. Co. Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of BCWORLD PHARM. Co. Ltd.

BCWORLD PHARM. Co. Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of BCWORLD PHARM. Co. Ltd.

BCWORLD PHARM. Co. Ltd Daily Average True Range (ATR) ChartBCWORLD PHARM. Co. Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of BCWORLD PHARM. Co. Ltd.

BCWORLD PHARM. Co. Ltd Daily On-Balance Volume (OBV) ChartBCWORLD PHARM. Co. Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of BCWORLD PHARM. Co. Ltd.

BCWORLD PHARM. Co. Ltd Daily Money Flow Index (MFI) ChartBCWORLD PHARM. Co. Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for BCWORLD PHARM. Co. Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-07-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-05RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-07-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-08-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-04STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-09MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-09-25MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-04RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-10-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-10-10BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-10-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-11-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-11-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-22STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

BCWORLD PHARM. Co. Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of BCWORLD PHARM. Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose4,600.000
Total1/1 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of BCWORLD PHARM. Co. Ltd with someone you think should read this too:
  • Are you bullish or bearish on BCWORLD PHARM. Co. Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about BCWORLD PHARM. Co. Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about BCWORLD PHARM. Co. Ltd

I send you an email if I find something interesting about BCWORLD PHARM. Co. Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about BCWORLD PHARM. Co. Ltd.

Receive notifications about BCWORLD PHARM. Co. Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.